LUNGevityKristin Posted October 15, 2020 Share Posted October 15, 2020 INFORM: NSCLC with MET Clinical Trial “You may qualify for a new clinical trial specific to your type of lung cancer. Massive Bio is working with a Pharmaceutical Sponsor to identify and determine eligibility of patients with MET-Altered Advanced Non-Small Cell Lung Cancer (NSCLC) to a novel drug in Phase 2 clinical trial. If you are interested in learning about this trial, please contact: Kristin Johnston, BSN, RN, Chief Nursing Officer, Massive Bio, Inc. Phone: 267-918-3790 Email: kjohnston@massivebio.com “ Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.